Qube Research & Technologies Ltd

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1729829 LONDON, X0

Back to REGN Full portfolio

Position in REGN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$64,405,725

-$45,341,067 QoQ

Shares Held

83,358

-41.4% QoQ

Ownership

0.080%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

20 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Derivatives in REGN

reported options exposure · as of Mar 31, 2026

CallValue

$6,490,176

CallShares

8,400

PutValue

$5,408,480

PutShares

7,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Qube Research & Technologies Ltd holds $2,033,804,065 across 186 Biotechnology names. REGN ranks #5 (3.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	838,187	$277,330,932
2	FOLD	AMICUS THERAPEUTICS, INC.	8,809,340	$127,383,056
3	ROIV	Roivant Sciences Ltd.	3,450,904	$95,590,040
4	RPRX	Royalty Pharma plc	1,524,511	$73,130,792
5	REGN	Regeneron Pharmaceuticals, Inc. This page	83,358	$64,405,725
6	AXSM	Axsome Therapeutics, Inc.	335,334	$56,678,152
7	RVMD	Revolution Medicines, Inc.	553,290	$53,807,452
8	CYTK	Cytokinetics Inc	779,446	$51,373,285

All Filings in REGN

Export CSV

38 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,408,480	7,000	-91.6%	Put	Sole	2026-05-15
2026-03-31	$64,405,725	83,358	+892.4%	Shares	Sole	2026-05-15
2026-03-31	$6,490,176	8,400	-66.0%	Call	Sole	2026-05-15
2025-12-31	$19,065,189	24,700	-82.6%	Put	Sole	2026-02-17
2025-12-31	$109,746,792	142,183	+390.3%	Shares	Sole	2026-02-17
2025-12-31	$22,384,230	29,000	-32.6%	Call	Sole	2026-02-17
2025-09-30	$24,177,610	43,000	-2.1%	Put	Sole	2025-11-14
2025-09-30	$24,683,653	43,900	-92.0%	Call	Sole	2025-11-14
2025-09-30	$308,536,666	548,734	-12.3%	Shares	Sole	2025-11-14
2025-06-30	$328,639,500	625,980	+1352.4%	Shares	Sole	2025-08-14
2025-06-30	$22,627,500	43,100	+8.6%	Put	Sole	2025-08-14
2025-06-30	$20,842,500	39,700	+402.5%	Call	Sole	2025-08-14
2025-03-31	$5,010,417	7,900	-98.9%	Call	Sole	2025-05-15
2025-03-31	$445,795,193	702,892	+1175.7%	Shares	Sole	2025-05-15
2025-03-31	$34,946,073	55,100	+2104.0%	Put	Sole	2025-05-15
2024-12-31	$1,780,825	2,500	-89.9%	Call	Sole	2025-02-14
2024-12-31	$17,665,784	24,800	-94.4%	Put	Sole	2025-02-14
2024-12-31	$314,603,393	441,654	+7514.7%	Shares	Sole	2025-02-14
2024-09-30	$6,097,192	5,800	-96.2%	Put	Sole	2024-11-14
2024-09-30	$159,755,891	151,969	+687.4%	Shares	Sole	2024-11-14
2024-06-30	$20,284,879	19,300	-90.0%	Put	Sole	2024-08-14
2024-06-30	$203,845,166	193,948	+103.5%	Shares	Sole	2024-08-14
2024-03-31	$91,725,297	95,300	-38.9%	Put	Sole	2024-05-14
2024-03-31	$150,002,140	155,848	+5894.2%	Shares	Sole	2024-05-14
2024-03-31	$2,502,474	2,600	-43.5%	Call	Sole	2024-05-14
2023-12-31	$4,040,134	4,600	-97.3%	Put	Sole	2024-02-13
2023-12-31	$150,507,287	171,364	+2883.9%	Shares	Sole	2024-02-13
2023-09-30	$4,726,259	5,743	-66.8%	Shares	Sole	2023-11-13
2023-09-30	$14,237,208	17,300	+282.8%	Put	Sole	2023-11-13
2023-03-31	$3,713,126	4,519	-95.8%	Shares	Sole	2023-05-15
2022-12-31	$76,967,831	106,679	+1288.5%	Shares	Sole	2023-02-14
2022-09-30	$5,292,588	7,683	-90.7%	Shares	Sole	2022-11-14
2022-06-30	$48,916,007	82,750	+759.3%	Shares	Sole	2022-08-15
2022-03-31	$6,725,784	9,630	-53.4%	Shares	Sole	2022-05-09
2021-12-31	$13,047,203	20,660	-43.6%	Shares	Sole	2022-02-10
2021-09-30	$22,176,821	36,645	+37.6%	Shares	Sole	2021-11-12
2020-12-31	$12,861,354	26,622	+13.4%	Shares	Sole	2021-02-16
2020-09-30	$13,138,036	23,470	—	Shares	Sole	2020-11-12
No filing history on record for this holder in this stock.